Healius Limited (ASX:HLS)
0.4100
0.00 (0.00%)
Oct 7, 2026, 4:10 PM AEST
Healius Market Cap
Healius has a market cap or net worth of 297.72 million as of October 7, 2026. Its market cap has decreased by -49.07% in one year.
Market Cap
297.72M
Enterprise Value
1.23B
Revenue
1.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
ChartMarket Cap Chart
Since August 29, 2000, Healius's market cap has decreased from 478.57M to 297.72M, a decrease of -37.79%. That is a compound annual growth rate of -1.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 297.72M | -54.69% |
| Dec 31, 2025 | 657.15M | -33.94% |
| Dec 31, 2024 | 994.80M | -16.20% |
| Dec 29, 2023 | 1.19B | -32.22% |
| Dec 30, 2022 | 1.75B | -43.13% |
| Dec 31, 2021 | 3.08B | 32.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.12B |
| Integral Diagnostics | 800.85M |
| Australian Clinical Labs | 516.28M |
| Monash IVF Group | 286.38M |
| Cryosite | 56.13M |
| Microba Life Sciences | 34.32M |
| BCAL Diagnostics | 32.08M |
| Rhythm Biosciences | 28.31M |